The FINANCIAL - Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access
Share This The FINANCIAL -- In a major boost to efforts to combat COVID-19 globally, a vaccine that recently entered human trials in Vietnam and Thailand, and is slated for a clinical study in Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines. The vaccine is the result of a partnership between The University of Texas at Austin, the Icahn School of Medicine at Mount Sinai in New York and global partners interested in advancing the supply of affordable vaccines to address the pandemic. The vaccine, NDV-HXP-S, can be stored at 2-8...
Source: finchannel.com